Immediate Impact

57 standout
Sub-graph 1 of 23

Citing Papers

Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation
2024 Standout
Vaccine adjuvants: mechanisms and platforms
2023 Standout
2 intermediate papers

Works of Andrzej Gałaj being referenced

Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age
2017
Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years
2008

Author Peers

Author Last Decade Papers Cites
Andrzej Gałaj 254 83 47 64 7 282
Lan Lin 270 88 26 82 9 313
Paola Colares de Borba 215 103 28 40 6 250
Ole-Erik Iversen 221 77 17 53 5 263
Erin Moeller 229 82 15 62 7 254
Li Liu 224 81 30 28 14 275
L Richardson 260 119 39 27 8 322
Qiong Shou 154 52 12 28 11 189
Jaime Alberto Restrepo 173 59 13 39 4 191
Nasreen Abdullah 145 67 19 22 8 200
F Pakarian 251 106 19 38 9 306

All Works

Loading papers...

Rankless by CCL
2026